Octimet Oncology Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Octimet Oncology General Information
Description
Developer of discovery-stage molecules designed to treat cancer cells. The company's molecules include cMET inhibitors and other highly selective anti-tumor molecules by employing patient selection, pharmacodynamic biomarker-based strategies, and clinical development approaches to provide differentiation both within the current treatment paradigms and from competitor agents using biotechnological therapeutics, enabling patients to get treatment for cancer.
Contact Information
Website
www.octimet.comCorporate Office
- Pieter Van Reysschootlaan 2/104
- Sint-Denijs-Westrem
- 9051 Ghent
- Belgium
Corporate Office
- Pieter Van Reysschootlaan 2/104
- Sint-Denijs-Westrem
- 9051 Ghent
- Belgium
Octimet Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Jan-2022 | Completed | Generating Revenue | |||
| 3. Grant | 08-Aug-2018 | Completed | Generating Revenue | |||
| 2. Grant | 09-Nov-2017 | $1.31M | $11.9M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 18-Jan-2017 | $11.9M | $11.9M | Completed | Generating Revenue |
Octimet Oncology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A2 | ||||||||
| Class A1 | ||||||||
| Class A2 | 50,694 | $9.58 | $9.58 | 1x | $9.58 | 8.42% |
Octimet Oncology Signals
Octimet Oncology Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| VLAIO | Limited Partner |
Octimet Oncology FAQs
-
When was Octimet Oncology founded?
Octimet Oncology was founded in 2016.
-
Where is Octimet Oncology headquartered?
Octimet Oncology is headquartered in Ghent, Belgium.
-
What is the size of Octimet Oncology?
Octimet Oncology has 5 total employees.
-
What industry is Octimet Oncology in?
Octimet Oncology’s primary industry is Drug Discovery.
-
Is Octimet Oncology a private or public company?
Octimet Oncology is a Private company.
-
What is Octimet Oncology’s current revenue?
The current revenue for Octimet Oncology is .
-
How much funding has Octimet Oncology raised over time?
Octimet Oncology has raised $11.9M.
-
Who are Octimet Oncology’s investors?
VLAIO has invested in Octimet Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process